US FDA invites biologics sponsors to participate in electronic submission pilot
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is inviting biologic drug makers to participate in a pilot programme to test the value of using its new electronic data standard format to submit non-clinical study data related to investigational new drug applications1.